Genomics, the study of genetic material and their functions, is currently being deployed in the battle against the COVID-19 virus. Genomic data of the virus and those of affected individuals help guide medical and public health interventions and ensure the effectiveness of treatments and policies. The Firm’s Ma. Sophia Editha C. Cruz-Abrenica and Patricia Cruz examine the history of genomics, its utilization to combat the spread of the COVID-19 virus, and the patentability of COVID-19 genomics in the Philippine setting.
